Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism
about
Cartilage oligomeric matrix protein is involved in human limb development and in the pathogenesis of osteoarthritisInhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulinADAMTS-12 associates with and degrades cartilage oligomeric matrix proteinProtection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritisAltered expression of inflammatory cytokines in primary osteoarthritis by human T lymphotropic virus type I retrovirus infection: a cross-sectional studyThe Function and Roles of ADAMTS-7 in Inflammatory DiseasesCurrent Status and Strategy of microRNA Research for Cartilage Development and Osteoarthritis PathogenesisBone sialoproteinCartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferationSerum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritisCartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis.The relationship of antibodies to modified citrullinated vimentin and markers of bone and cartilage destruction in rheumatoid arthritis.ADAMTS-12: a multifaced metalloproteinase in arthritis and inflammationDegradation of extracellular matrix molecules in interleukin-1α treated bovine nasal cartilageSynovial cell death is regulated by TNF-α-induced expression of B-cell activating factor through an ERK-dependent increase in hypoxia-inducible factor-1αInteraction between cartilage oligomeric matrix protein and extracellular matrix protein 1 mediates endochondral bone growth.Novel cartilage oligomeric matrix protein (COMP) neoepitopes identified in synovial fluids from patients with joint diseases using affinity chromatography and mass spectrometry.Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritis.Structure and function of aggrecan.Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy.The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration.ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix proteinEarly increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritisRadiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis.Progranulin: a promising therapeutic target for rheumatoid arthritis.Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis.Markers of joint destruction: principles, problems, and potential.Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation.Prognostic laboratory markers of joint damage in rheumatoid arthritis.The relation between cartilage biomarkers (C2C, C1,2C, CS846, and CPII) and the long-term outcome of rheumatoid arthritis patients within the CAMERA trial.Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis.Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genesEnhanced COMP catabolism detected in serum of patients with arthritis and animal disease models through a novel capture ELISA.Biomarkers for diagnosing and monitoring autoimmune diseases.Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study.Application of biomarkers in the clinical development of new drugs for chondroprotection in destructive joint diseases: a review.ADAMTS-7, a direct target of PTHrP, adversely regulates endochondral bone growth by associating with and inactivating GEP growth factor.Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis.Collagen biomarkers for arthritis applications.
P2860
Q24307967-70C1F159-B2A2-425D-AE69-0F86523F8B12Q24313406-FBF2F1CB-249D-4F45-83D8-F7FE057FC347Q24317122-D28704AA-8C63-42ED-B5DA-3C228119EDE7Q24792053-7936D955-56A6-4A27-A838-46FB7511AED8Q24805471-7A05A32E-E75C-4116-B1A3-DBB36D2F75C2Q26773190-9E5131DF-EB84-43FF-BE56-A1669505F60FQ28076229-C504B434-A2EC-4952-80C0-327EED4A1A38Q28141497-D3100963-2738-4A03-A673-A7E10E6BB858Q28569341-DED298E5-6E0A-45BB-BFF8-1C8C09F945B8Q33265934-5C4BB63B-8E85-4366-AAB9-10F16B4C33B0Q33384917-259B5C86-7AB7-4A6C-84AE-A6B9C93F53D6Q33563097-7E01F6CD-B2B6-4569-8195-6DF56605B565Q33607501-D3A2FCCD-1E10-49E4-BB89-25CCB671A8E3Q33808481-0BFDA7AB-35CA-46D5-9CB6-E9E6F56E8AE5Q33815933-5E11DCBD-B61A-4295-9E2B-1D80AE6EFAEDQ33823788-3CF97AE9-C6F7-410F-8BC9-BA62183D310CQ33947178-2D3A9DA7-5F56-4E75-9393-0F74FB21FEE0Q34118568-0D201586-E058-49EF-9884-82B3E13931AFQ34122868-A1C758CD-0F89-4F10-80E0-E1EB220D53A6Q34281891-2ACC0859-A6FF-49C1-A9EB-5929B747B1B0Q34393687-A7D90EBF-EA7B-4984-ADF8-41735EC503E3Q34508676-D8722267-8E97-4991-824B-BA04F602A27CQ34894822-E06D5995-AF86-4C39-9CE5-14E02AB06C34Q34896346-270AD7E4-3BBF-4240-96DA-49D42F81E4CEQ35182029-08F9B5C1-C921-43EC-93DC-45BEA5C29011Q35549724-E99E2FFF-F8A4-4AEF-B893-618D4D528B7AQ35550491-C96F77F3-BDB2-4AC6-8765-5BD36EE82411Q35550507-D9B1E537-AF94-4FD5-BFFE-5D101DF8327EQ35551481-FDFCF984-2C28-47AC-9CCA-1505092A5D30Q35555179-9BE84D20-C13A-44FE-BE60-7A0ED08493A0Q35557805-02BEE5C1-5098-4029-BFD1-091A4F2EC30FQ35638162-CFE7EADF-2F83-4649-BB25-456DDBBBD2E6Q35782480-6B4DD0E6-DFF6-4789-B233-16C48602F88AQ36074512-FBFECBB8-50ED-4F95-BE5F-C976CDAB319AQ36318003-40E46A1C-BEDC-4C19-AB26-856A0658C59DQ36401945-20F21E63-F30D-4BBA-9E3A-157A6E737249Q36631211-C111F975-A972-4E33-9EA8-A97C6CF7BE48Q37275142-CFF80F15-624F-43F3-8458-AA4CE8885A7AQ37277626-D0EBF031-8F3A-46F7-ACA5-FE08E0A7E4CCQ37277952-DC3E863E-9BB5-4F7F-AC84-C4193F08A74F
P2860
Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Cartilage and bone metabolism ...... arkers of cartilage metabolism
@ast
Cartilage and bone metabolism ...... arkers of cartilage metabolism
@en
Cartilage and bone metabolism ...... arkers of cartilage metabolism
@nl
type
label
Cartilage and bone metabolism ...... arkers of cartilage metabolism
@ast
Cartilage and bone metabolism ...... arkers of cartilage metabolism
@en
Cartilage and bone metabolism ...... arkers of cartilage metabolism
@nl
prefLabel
Cartilage and bone metabolism ...... arkers of cartilage metabolism
@ast
Cartilage and bone metabolism ...... arkers of cartilage metabolism
@en
Cartilage and bone metabolism ...... arkers of cartilage metabolism
@nl
P2093
P2860
P3181
P356
P1476
Cartilage and bone metabolism ...... arkers of cartilage metabolism
@en
P2093
D Heinegård
L C Rosenberg
P2860
P304
P3181
P356
10.1172/JCI117753
P407
P577
1995-03-01T00:00:00Z